Published in Psychopharmacology (Berl) on January 24, 2006
Premenstrual syndrome. Lancet (2008) 2.92
GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron (2008) 2.55
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci U S A (2006) 2.01
The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry (2010) 1.80
Mechanisms of neurosteroid interactions with GABA(A) receptors. Pharmacol Ther (2007) 1.60
Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice. Proc Natl Acad Sci U S A (2007) 1.23
Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder. Proc Natl Acad Sci U S A (2008) 1.22
SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol (2009) 1.15
Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry (2009) 1.14
Stress responses and the mesolimbic dopamine system: social contexts and sex differences. Horm Behav (2011) 1.06
Prozac during puberty: distinctive effects on neurogenesis as a function of age and sex. Neuroscience (2009) 1.03
Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy. Epilepsy Behav (2012) 1.03
Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression. Psychopharmacology (Berl) (2010) 1.03
mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway. Transl Psychiatry (2013) 0.98
A reproductive subtype of depression: conceptualizing models and moving toward etiology. Harv Rev Psychiatry (2009) 0.98
Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl Psychiatry (2013) 0.98
Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice. J Pharmacol Exp Ther (2009) 0.94
The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment. Epilepsy Behav (2008) 0.93
Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits. Biol Psychiatry (2013) 0.92
Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder. J Neuroendocrinol (2012) 0.92
Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation. Proc Natl Acad Sci U S A (2006) 0.91
Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment. BMC Genomics (2013) 0.90
Behavioral and pharmacogenetics of aggressive behavior. Curr Top Behav Neurosci (2012) 0.90
Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain. PLoS One (2009) 0.88
Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial. JAMA Psychiatry (2015) 0.88
Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder. Front Cell Neurosci (2014) 0.87
The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders. Cell Mol Neurobiol (2007) 0.87
In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis. Behav Pharmacol (2010) 0.86
Fluoxetine improves the effect of levodopa on 6-hydroxy dopamine-induced motor impairments in rats. Adv Pharm Bull (2012) 0.86
GABAergic control of depression-related brain states. Adv Pharmacol (2015) 0.86
S-norfluoxetine microinfused into the basolateral amygdala increases allopregnanolone levels and reduces aggression in socially isolated mice. Neuropharmacology (2010) 0.85
Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility. Pharmacol Biochem Behav (2007) 0.84
Rapid response to fluoxetine in women with premenstrual dysphoric disorder. Depress Anxiety (2012) 0.84
New perspectives in neurosteroid action: open questions for future research. Front Cell Neurosci (2014) 0.83
Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression. Front Endocrinol (Lausanne) (2011) 0.83
Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia? Neurotherapeutics (2009) 0.82
Targeting neurosteroidogenesis as therapy for PTSD. Front Pharmacol (2014) 0.81
Hypothesis: the role of sterols in autism spectrum disorder. Autism Res Treat (2011) 0.81
Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels. Neuropsychopharmacology (2015) 0.80
Investigation of the anticonvulsive effect of acute immobilization stress in anxious Balb/cByJ mice using GABA A-related mechanistic probes. Psychopharmacology (Berl) (2008) 0.80
GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism. Schizophr Res (2014) 0.79
Menstrual effects on mood symptoms in treated women with bipolar disorder. Bipolar Disord (2011) 0.79
Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment. Br J Pharmacol (2017) 0.79
Progesterone attenuates depressive behavior of younger and older adult C57/BL6, wildtype, and progesterone receptor knockout mice. Pharmacol Biochem Behav (2011) 0.78
5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients. Psychopharmacology (Berl) (2014) 0.78
A neurochemical basis for an epigenetic vision of psychiatric disorders (1994-2009). Pharmacol Res (2011) 0.77
Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients. Neuropsychiatr Dis Treat (2013) 0.77
Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models. Front Behav Neurosci (2014) 0.77
5-HT1A/1B receptors as targets for optimizing pigmentary responses in C57BL/6 mouse skin to stress. PLoS One (2014) 0.77
Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia. J Neural Transm (Vienna) (2009) 0.76
Neurosteroids as neuromodulators in the treatment of anxiety disorders. Front Endocrinol (Lausanne) (2011) 0.76
Sleep disturbance as detected by actigraphy in pre-pubertal juvenile monkeys receiving therapeutic doses of fluoxetine. Neurotoxicol Teratol (2016) 0.76
Further Electrochemical and Behavioural Evidence of a Direct Relationship Between Central 5-HT and Cytoskeleton in the Control of Mood. Open Neurol J (2010) 0.76
Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase. Br J Pharmacol (2014) 0.75
The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis. PLoS One (2015) 0.75
Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study. Psychoneuroendocrinology (2017) 0.75
Cross-Species Translational Findings in the Discriminative Stimulus Effects of Ethanol. Curr Top Behav Neurosci (2017) 0.75
A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl) (2017) 0.75
The antidepressant-like effects of topiramate alone or combined with 17β-estradiol in ovariectomized Wistar rats submitted to the forced swimming test. Psychopharmacology (Berl) (2013) 0.75
Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression. Sci Signal (2017) 0.75
An emerging role for the lateral habenula in aggressive behavior. Pharmacol Biochem Behav (2017) 0.75
Neurobiology of depression. Neuron (2002) 8.56
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature (1998) 4.09
Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci (2005) 4.07
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Current advances and trends in the treatment of depression. Trends Pharmacol Sci (1994) 3.49
Neuroactive steroids. FASEB J (1992) 3.41
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci (1999) 2.76
Neurosteroids act on recombinant human GABAA receptors. Neuron (1990) 2.44
Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol (1992) 2.35
The biochemistry of affective disorders. Br J Psychiatry (1967) 2.31
Anticonvulsant effect of fluoxetine in humans. Neurology (1995) 2.20
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A (1998) 2.12
Is mood chemistry? Nat Rev Neurosci (2005) 2.12
The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors. Neuropharmacology (2002) 1.85
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) (2005) 1.82
Neurosteroid modulation of GABAA receptors. Prog Neurobiol (2003) 1.80
Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents. Mol Pharmacol (1991) 1.73
Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci U S A (2005) 1.71
Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience (2004) 1.66
Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry (1997) 1.59
Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A (1998) 1.58
Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther (1988) 1.53
Neurosteroids: beginning of the story. Int Rev Neurobiol (2001) 1.52
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A (1999) 1.51
Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet (1994) 1.45
History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry (2000) 1.43
Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci U S A (1996) 1.42
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology (2003) 1.42
Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci U S A (2001) 1.41
Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J Neurosci (1995) 1.31
Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one. Eur J Pharmacol (1989) 1.29
The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev (1997) 1.25
Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry (2001) 1.25
Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry (1965) 1.24
Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J Pharmacol Exp Ther (2000) 1.24
Stress and neuroactive steroids. Int Rev Neurobiol (2001) 1.24
Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss. Neuropharmacology (1999) 1.23
Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Mol Psychiatry (2005) 1.23
Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology (2005) 1.20
The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res Brain Res Rev (2001) 1.19
From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov (2004) 1.18
Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.17
In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci U S A (2003) 1.14
On the putative physiological role of allopregnanolone on GABA(A) receptor function. Neuropharmacology (2003) 1.13
Pregnenolone sulfate antagonizes GABAA receptor-mediated currents via a reduction of channel opening frequency. Brain Res (1989) 1.11
Does neurosteroid modulatory efficacy depend on GABAA receptor subunit composition? Receptors Channels (1993) 1.08
Chronic stress and social housing differentially affect neurogenesis in male and female rats. Brain Res Bull (2004) 1.08
Structure-activity relationships in steroidal anaesthetics. J Steroid Biochem (1975) 1.07
Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. J Clin Psychiatry (2000) 1.06
Benzodiazepines on trial: a research strategy for their rehabilitation. Trends Pharmacol Sci (1996) 1.06
Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav (2000) 1.05
Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl) (2000) 1.04
Brain allopregnanolone regulates the potency of the GABA(A) receptor agonist muscimol. Neuropharmacology (2000) 1.03
2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J Pharmacol Exp Ther (1992) 1.03
Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability? Biol Psychiatry (1998) 1.01
Alprazolam dependence prevented by substituting with the beta-carboline abecarnil. Proc Natl Acad Sci U S A (1997) 1.01
Neurosteroids in depression: a review. Psychopharmacology (Berl) (2002) 0.99
Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs. Crit Rev Neurobiol (2004) 0.98
Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis. Stress (2005) 0.98
Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav (1993) 0.97
Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids. Proc Natl Acad Sci U S A (2004) 0.95
Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc Natl Acad Sci U S A (2005) 0.95
Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors? J Affect Disord (1996) 0.95
Hyperactivity of central noradrenergic and CRF systems is involved in social isolation-induced decrease in pentobarbital sleep. Brain Res (1995) 0.93
Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond. J Clin Psychiatry (2004) 0.93
Serotonin and its place in the pathogenesis of depression. J Clin Psychiatry (1988) 0.92
GABAA receptors and benzodiazepines: a role for dendritic resident subunit mRNAs. Neuropharmacology (2002) 0.92
Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats. Neuropharmacology (2005) 0.91
How antidepressants help depression: mechanisms of action and clinical response. J Clin Psychiatry (2004) 0.91
Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain. Neuropsychopharmacology (1993) 0.90
Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. Eur J Pharmacol (2004) 0.90
Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.85
Neurosteroids and neuroactive drugs in mental disorders. Life Sci (2004) 0.84
Long-term social isolation enhances picrotoxin seizure susceptibility in mice: up-regulatory role of endogenous brain allopregnanolone in GABAergic systems. Pharmacol Biochem Behav (2003) 0.84
Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives. J Pharmacol Exp Ther (1993) 0.84
Brain neurosteroids in gender-related aggression induced by social isolation. Crit Rev Neurobiol (2004) 0.83
Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard? Drugs (2002) 0.83
Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder. Psychiatry Res (2005) 0.82
Psychopharmacology of aggression: an overview. Int Pharmacopsychiatry (1981) 0.81
Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice. Brain Res (2000) 0.81
Neuroactive steroids and anxiety disorders. J Psychiatry Neurosci (2002) 0.81
The dual-action hypothesis: does pharmacology matter? J Clin Psychiatry (2004) 0.80
The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res (1996) 0.80
Tianeptine decreases both serotonin transporter mRNA and binding sites in rat brain. Eur J Pharmacol (1994) 0.79
Neurosteroidal modulation of social isolation-induced decrease in pentobarbital sleep in mice. Brain Res (1996) 0.78
Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice. Brain Res (2004) 0.77
Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase. Clin Neuropharmacol (1988) 0.77
The role of fluoxetine in the treatment of premenstrual dysphoric disorder. Clin Ther (1999) 0.77
Selective versus multi-transmitter antidepressants: are two mechanisms better than one? J Clin Psychiatry (2004) 0.76
Fluoxetine and seizures. Neurology (1996) 0.75
Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis. J Clin Psychiatry (2004) 0.75
Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A (2005) 3.12
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci U S A (2006) 2.01
DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol (2006) 1.95
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) (2005) 1.82
Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry (2005) 1.74
In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci U S A (2005) 1.72
Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability. Epigenetics (2007) 1.70
On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res (2002) 1.69
The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology (2012) 1.40
A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes. Proc Natl Acad Sci U S A (2003) 1.38
Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res (2007) 1.34
The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacol Ther (2006) 1.32
DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc Natl Acad Sci U S A (2005) 1.26
Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice. Proc Natl Acad Sci U S A (2007) 1.23
The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol (2008) 1.22
Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder. Proc Natl Acad Sci U S A (2008) 1.22
Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology (2012) 1.21
Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics (2010) 1.20
Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry (2006) 1.19
Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr Res (2006) 1.18
Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci (2008) 1.17
Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology (2011) 1.17
S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport (2007) 1.17
Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J Neurochem (2005) 1.16
SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol (2009) 1.15
Chronic intermittent ethanol (CIE) administration in rats decreases levels of neurosteroids in hippocampus, accompanied by altered behavioral responses to neurosteroids and memory function. Neuropharmacology (2004) 1.15
In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci U S A (2003) 1.14
In Patas monkey, glutamic acid decarboxylase-67 and reelin mRNA coexpression varies in a manner dependent on layers and cortical areas. J Comp Neurol (2002) 1.07
Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem Res (2008) 1.03
The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr Opin Pharmacol (2002) 1.02
Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology (2011) 0.99
Reelin down-regulation in mice and psychosis endophenotypes. Neurosci Biobehav Rev (2006) 0.99
Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis. Stress (2005) 0.98
Olfactory discrimination learning deficit in heterozygous reeler mice. Brain Res (2003) 0.98
Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression. Proc Natl Acad Sci U S A (2010) 0.97
Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain. Mol Pharmacol (2011) 0.97
GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability. Expert Rev Neurother (2009) 0.96
From trans-methylation to cytosine methylation: evolution of the methylation hypothesis of schizophrenia. Epigenetics (2009) 0.96
Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids. Proc Natl Acad Sci U S A (2004) 0.95
Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc Natl Acad Sci U S A (2005) 0.95
Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention? Mol Interv (2003) 0.95
GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit Rev Neurobiol (2003) 0.94
Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation. Proc Natl Acad Sci U S A (2006) 0.91
Chromatin, DNA methylation and neuron gene regulation--the purpose of the package. J Psychiatry Neurosci (2005) 0.91
Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage. Toxicology (2008) 0.88
Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia. Schizophr Res (2013) 0.88
Imidazenil: a low efficacy agonist at alpha1- but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem. Neuropharmacology (2008) 0.87
DNA methyltransferases1 (DNMT1) and 3a (DNMT3a) colocalize with GAD67-positive neurons in the GAD67-GFP mouse brain. J Comp Neurol (2012) 0.86
Advancing drug discovery for schizophrenia. Ann N Y Acad Sci (2011) 0.86
Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons. Neuropsychopharmacology (2011) 0.86
Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation. Epigenomics (2009) 0.84
The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice. Proc Natl Acad Sci U S A (2008) 0.84
Imidazenil: a potent and safe protective agent against diisopropyl fluorophosphate toxicity. Neuropharmacology (2004) 0.83
Brain neurosteroids in gender-related aggression induced by social isolation. Crit Rev Neurobiol (2004) 0.83
L-methionine decreases dendritic spine density in mouse frontal cortex. Neuroreport (2010) 0.80
Acute imidazenil treatment after the onset of DFP-induced seizure is more effective and longer lasting than midazolam at preventing seizure activity and brain neuropathology. Toxicol Sci (2010) 0.80
Should allosteric positive modulators of GABA(A) receptors be tested in the treatment of schizophrenia? Schizophr Res (2005) 0.79
Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives. Pharmacol Biochem Behav (2010) 0.79
5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients. Psychopharmacology (Berl) (2014) 0.78
Absence of tolerance to the anticonvulsant and neuroprotective effects of imidazenil against DFP-induced seizure and neuronal damage. Neuropharmacology (2011) 0.78
Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers. Schizophr Res (2010) 0.77
Gene profiling of laser-microdissected brain regions and individual cells in drug abuse and schizophrenia research. Methods Mol Biol (2012) 0.77
Imidazenil: an antagonist of the sedative but not the anticonvulsant action of diazepam. Neuropharmacology (2005) 0.76
[Stress and sleep/emotional disorder: possible involvement of neurosteroid allopregnanolone]. Nihon Yakurigaku Zasshi (2005) 0.76
Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review. Curr Neuropharmacol (2016) 0.76